Dr. Kenneth R. Morris
Director of the Lachman Institute for Pharmaceutical Analysis and University Professor, College of Pharmacy, Long Island University
Dr. Kenneth R. Morris received a dual B.S. in Chemistry and Aquatic Biology from Eastern Michigan University in 1978 an M.S. in Pharmaceutical Chemistry from the University of Arizona (1986) and his Ph.D. from the University of Arizona in 1988. After getting his Ph.D., he joined E.R. Squibb and Sons. There he developed the Physical Characterization group and co-developed the Materials Science function. He went on to form the Pre-formulation/Physical Pharmacy group in the Bristol-Myers Products organization, which he led along with Analytical Chemistry. During his time at BMS he also served as a teaching and advising adjunct professor at Rutgers College of Pharmacy and St. Johns University.
Dr. Morris then moved to the department of Industrial and Physical Pharmacy at Purdue University in the fall of 1997 where he continued his work in Pharmaceutical Materials Science and Industrial Pharmacy. He was also a professor and associate head for the department. In 2008 Dr. Morris moved to the University of Hawaii at Hilo to help establish the new College of Pharmacy and Ph.D. program in Pharmaceutical Sciences. He also served as the Department Chair from 2012-2015 and Chair of the Graduate Council for the University.
In 2015 Dr. Morris moved to Long Island University as a University Professor and founding Director of the Lachman Institute for Pharmaceutical Analysis. His research and teaching interests include: analytical tools for solid state characterization; the study of the impact of processing on the physical characteristics of formulation components and on subsequent dosage form performance; pharmaceutical unit operation optimization; advanced applications of powder x-ray diffraction and dielectric analysis; the study of the association of water with pharmaceutical solids; and modeling and methods for monitoring processing unit operations.
Dr. Morris is an AAPS fellow (American Association of Pharmaceutical Scientists) and was the Purdue University Site leader for the NSF Engineering Research Center for Structured Organic Composites (ERC-SOPS). Professor Morris is a special government employee and past-chair of the U.S. FDA Scientific Advisory Committee for the Office of Pharmaceutical Sciences (ACPS-OPS) advising the agency in his areas of expertise.